Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus

BACKGROUND: Alpha‐glucosidase inhibitors (AGI) reduce blood glucose levels and may thus prevent or delay type 2 diabetes mellitus (T2DM) and its associated complications in people at risk of developing of T2DM. OBJECTIVES: To assess the effects of AGI in people with impaired glucose tolerance (IGT),...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cochrane Database Syst Rev
Auteurs principaux: Moelands, Suzanne VL, Lucassen, Peter LBJ, Akkermans, Reinier P, De Grauw, Wim JC, Van de Laar, Floris A
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2018
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6517235/
https://ncbi.nlm.nih.gov/pubmed/30592787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005061.pub3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires